PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 87 filers reported holding PMV PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,420,000 | -3.8% | 3,000,000 | -2.0% | 0.29% | +10.4% |
| Q2 2023 | $19,155,600 | +31.2% | 3,060,000 | 0.0% | 0.26% | +20.4% |
| Q1 2023 | $14,596,200 | -45.2% | 3,060,000 | 0.0% | 0.22% | -45.7% |
| Q4 2022 | $26,622,000 | -26.9% | 3,060,000 | 0.0% | 0.40% | -40.9% |
| Q3 2022 | $36,414,000 | -17.6% | 3,060,000 | -1.3% | 0.67% | -22.9% |
| Q2 2022 | $44,175,000 | -3.6% | 3,100,000 | +40.9% | 0.87% | +4.4% |
| Q1 2022 | $45,804,000 | +35.3% | 2,200,000 | +50.2% | 0.84% | +45.1% |
| Q4 2021 | $33,842,000 | -61.2% | 1,465,000 | -49.9% | 0.58% | -57.9% |
| Q3 2021 | $87,165,000 | +39.8% | 2,925,000 | +60.3% | 1.37% | +26.3% |
| Q2 2021 | $62,342,000 | -19.7% | 1,825,000 | -22.7% | 1.08% | -19.2% |
| Q1 2021 | $77,629,000 | -40.5% | 2,360,267 | +0.4% | 1.34% | -40.3% |
| Q4 2020 | $130,536,000 | +126.7% | 2,350,267 | +27.0% | 2.25% | +174.8% |
| Q3 2020 | $57,578,000 | – | 1,850,000 | – | 0.82% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Capital LLC | 2,336,909 | $48,654,000 | 28.27% |
| INTERWEST VENTURE MANAGEMENT CO | 3,234,911 | $67,351,000 | 25.73% |
| OUP Management Co., LLC | 989,232 | $20,596,000 | 15.68% |
| Nextech Invest Ltd. | 1,385,807 | $28,853,000 | 8.24% |
| Boxer Capital, LLC | 3,498,636 | $72,842,000 | 3.74% |
| COWEN AND COMPANY, LLC | 1,261,529 | $26,265,000 | 2.53% |
| Orbimed Advisors | 6,855,423 | $142,730,000 | 2.31% |
| RTW INVESTMENTS, LP | 3,872,154 | $80,618,000 | 1.67% |
| PERSONAL CFO SOLUTIONS, LLC | 350,342 | $7,294,000 | 1.44% |
| ACUTA CAPITAL PARTNERS, LLC | 135,500 | $2,821,000 | 1.32% |